rPA reteplase data

Preliminary data from the first 280 patients enrolled in Boehringer's 324-patient RAPID 2 trial showed statistically significant improvement of the German company's drug over GNE's tPA in the numbers of open heart arteries.

Rates of complete flow in the infarcted artery at 90 minutes were 61 percent in the rPA group versus 44 percent in the tPA group (p=0.004). At 60 minutes, patency was 52 percent for rPA and 36 percent for tPA. ...